Abstract
NOD2, an intracellular sensor of bacteria, are linked to increased susceptibility to bacteria in Crohn’s disease (CD). The NOD2 protein is expressed mainly by macrophages and dendritic cells. This study is to examine the role of NOD2 in the innate response of macrophages to bacterial challenge. First, peritoneal macrophages and alveolar macrophages were harvested from WT, Nod22939iC, as well as TLR4−/− mice and incubated with E. coli or P. aeruginosa. Bacterial killing activity; IL-1β and TLR4 protein expression; NF-κB DNA binding activity assay; as well as IL-1β, TNFα, TLR2, TLR4 and TLR9 mRNA expression of macrophages were examined. We found that alveolar macrophages and peritoneal macrophages of Nod22939iC mice but not WT mice or TLR4−/− mice demonstrated a significant increase of E. coli killing activity. Bacterial challenge also induced a significant increase of pro-IL-1β protein expression; NF-κB DNA binding activity; as well as IL-1β and TNFα mRNA expression of the peritoneal macrophages in Nod22939iC mice. Collectively, the increase of bacterial killing activity, IL-1β expression, and NF-κB DNA binding activity of macrophages in Nod22939iC mice suggests that NOD2 is a positive regulator of NF-κB/IL-1β-mediated innate response to bacteria challenge in Crohn’s disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. Cezard, J. Belaiche, S. Almer, C. Tysk, C. A. O’Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411(6837):599–603.
Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411(6837):603–606.
Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278(11):8869–8872.
Hsu, L. C., S. R. Ali, S. McGillivray, P. H. Tseng, S. Mariathasan, E. W. Humke, L. Eckmann, J. J. Powell, V. Nizet, V. M. Dixit, et al. 2008. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. U. S. A. 105(22):7803–7808.
Traub, S., N. Kubasch, S. Morath, M. Kresse, T. Hartung, R. R. Schmidt, and C. Hermann. 2004. Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J. Biol. Chem. 279(10):8694–8700.
Uehara, A., S. Yang, Y. Fujimoto, K. Fukase, S. Kusumoto, K. Shibata, S. Sugawara, and H. Takada. 2005. Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7(1):53–61.
Rothwarf, D. M., and M. Karin. 1999. The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus. Sci. STKE. 1999(5):RE1.
Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18:621–663.
Gan, H. T., Y. Q. Chen, and Q. Ouyang. 2005. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. J. Gastroenterol. Hepatol. 20(7):1016–1024.
Maeda, S., L. C. Hsu, H. Liu, L. A. Bankston, M. Iimura, M. F. Kagnoff, L. Eckmann, and M. Karin. 2005. Nod2 mutation in Crohn’s disease potentiates NF-kappaB activity and IL-1beta processing. Science 307(5710):734–738.
Sayek, I. 1997. Animal models for intra-abdominal infection. Hepatogastroenterology 44(16):923–926.
van Westerloo, D. J., S. Weijer, M. J. Bruno, A. F. de Vos, C. Van’t Veer, and T. van der Poll. 2005. Toll-like receptor 4 deficiency and acute pancreatitis act similarly in reducing host defense during murine Escherichia coli peritonitis. Crit. Care Med. 33(5):1036–1043.
Chen, L. W., L. Egan, Z. W. Li, F. R. Greten, M. F. Kagnoff, and M. Karin. 2003. The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9(5):575–581.
Li, N., and M. Karin. 1998. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. U. S. A. 95(22):13012–13017.
Fiocchi, C. 1998. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115(1):182–205.
Podolsky, D. K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347(6):417–429.
Wahl, C., S. Liptay, G. Adler, and R. M. Schmid. 1998. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101(5):1163–1174.
Hisamatsu, T., M. Suzuki, H. C. Reinecker, W. J. Nadeau, B. A. McCormick, and D. K. Podolsky. 2003. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124(4):993–1000.
Watanabe, T., A. Kitani, P. J. Murray, and W. Strober. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5(8):800–808.
Mahida, Y. R., and V. E. Rolfe. 2004. Host–bacterial interactions in inflammatory bowel disease. Clin. Sci. (Lond.). 107(4):331–341.
Acknowledgements
This work was supported by grants from National Science Council (NSC932314B075B005), Kaohsiung Veterans General Hospital (VGHNSU93-04, VGHKS93-94), National Sun Yat-Sen University-Kaohsiung Medical University Joint Research Center, and VTY Joint Research Program, Tsou’s Foundation (VTY92-P3-19) to CLW. The authors have declared that no conflict of interest exists.
Author information
Authors and Affiliations
Corresponding author
Additional information
Tzyy-Bin Tsay and Chien-Jen Chang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tsay, TB., Chang, CJ., Chen, PH. et al. Nod2 Mutation Enhances NF-kappaB Activity and Bacterial Killing Activity of Macrophages. Inflammation 32, 372–378 (2009). https://doi.org/10.1007/s10753-009-9145-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-009-9145-z